2008•Annals of OncologyOpen access

Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa

Dominik Berthold, Gregory R. Pond, Ronald de Wit, Mario A. Eisenberger, Ian F. Tannock

Open full text 107 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 107 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Mitoxantrone, Docetaxel, Medicine, Oncology, Prostate cancer, Internal medicine, Crossover study, Chemotherapy

Back to paper search Browse research topics Original source

Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa — Research Paper | ScholarLens